FDA Inspection 736344 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007725025

The FDA completed an inspection of Octapharma Plasma, Inc. on July 21, 2011 in Greenville, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Greenville, MS (United States)